Global Pediatric Advisor/Senior Global Clinical Development Leader
Bayer HealthCare Pharmaceuticals, Inc.
Whippany, New Jersey, United States
Esther De La Cuesta, MD, MBA, serves as the Global Pediatric Advisor and Senior Global Clinical Development Leader in Oncology for Clinical Development and Operations at Bayer HealthCare Pharmaceuticals Inc.
Dr. Esther De La Cuesta has 27 years of experience in the pharmaceutical industry, working across therapeutic areas such as oncology, cardiovascular, and immunology. Her background includes drug development throughout all phases, medical affairs, business development, and pharmacovigilance, supporting regulatory submissions, product launches, and post-marketing safety activities.
She has held roles with increasing responsibility and strategic scope at Rhone Poulenc Rorer (Aventis), Bristol Myers Squibb, Abbott (AbbVie), Vertex, and Takeda, where she managed geographic expansion of established products into emerging markets. She joined Bayer in 2017 as Therapeutic Area Head – Oncology (TKIs/ADCs/Loxo) in Benefit Risk Management, then transitioned to Research and Development Oncology as Senior Clinical Development Leader, overseeing the pediatric program (SCOUT) for Larotrectinib and Regorafenib. She contributed to two NDAs (ODAC) and one EMDAC, and has experience interacting with global regulatory authorities including FDA, EMA, HC, MHRA, PMDA, and BfArM.
Dr. De La Cuesta earned her MD from the University of St. Thomas in the Philippines and an MBA in Healthcare from Penn State University.
Thursday, November 13, 2025
10:30 AM - 11:30 AM EST
Disclosure information not submitted.
